InvestorsHub Logo
Followers 36
Posts 8284
Boards Moderated 0
Alias Born 04/14/2011

Re: ANS414 post# 4184

Tuesday, 09/29/2020 3:54:41 AM

Tuesday, September 29, 2020 3:54:41 AM

Post# of 5070
End of 3rd qtr is this: Data update from
BCX9930 200/400mg treatment-naïve PNH
dose-ranging study. (Berotralstat)

End of 4th qtr is Galidesivir update.

See www.biocryst.com Events and Presentations. Then look at latest slides from recent presentation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BCRX News